跳转至内容
Merck

860432P

Avanti

C24:1 Galactosyl(α) Ceramide (d18:1/24:1(15Z))

D-galactosyl- α-1,1′ N-nervonoyl- D-erythro-sphingosine, powder

别名:

C24:1 α-D-galactosyl ceramide; N-(15Z-tetracosenoyl)-1-α-galactosyl-sphing-4-enine

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C48H91NO8
分子量:
810.24
分類程式碼代碼:
12352211
NACRES:
NA.25

化驗

>99% (TLC)

形狀

powder

包裝

pkg of 1 × 5 mg (860432P-5mg)

製造商/商標名

Avanti Research - A Croda Brand 860432P

脂質類型

sphingolipids

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

[H][C@]([C@@]([H])(/C=C/CCCCCCCCCCCCC)O)(NC(CCCCCCCCCCCCC/C=C\CCCCCCCC)=O)CO[C@@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O

包裝

5 mL Amber Glass Screw Cap Vial (860432P-5mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids

閃點(°F)

No data available

閃點(°C)

No data available


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Johanna von Gerichten et al.
Journal of lipid research, 58(6), 1247-1258 (2017-04-05)
Mammals synthesize, cell-type specifically, the diastereomeric hexosylceramides, β-galactosylceramide (GalCer) and β-glucosylceramide (GlcCer), which are involved in several diseases, such as sphingolipidosis, diabetes, chronic kidney diseases, or cancer. In contrast, Bacteroides fragilis, a member of the human gut microbiome, and the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门